RANJANA NIGALYE: Open Payments
NPI 1477541886 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 11 payments from 7 companies in 2025. Trend: 2023 $279 · 2024 $347 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $86 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: Ozempic, Rybelsus, SHINGRIX, Wegovy, PANHEMATIN, QULIPTA, ELIQUIS, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
